$68.6M in expenses

Distribution: the joint restoration foundation (the organization) maximizes the gift of human donated tissue by restoring movement and enhancing the quality of life for recipients of this tissue. As the leading provider of fresh cartilage allografts for joint repair, and one of the nation's largest providers of allograft tissue for sports medicine, the organization works with the medical community to match clinical indications with the correctly sized allograft tissue to enable successful outcomes (enhanced mobility) for over 4,000 recipients we help annually. The organization's staff are fully trained on the use of allograft tissue, enabling them to discuss options with surgeons and other medical personnel.

$2.5M in expenses

Grants, research and charitable contributions: joint restoration foundation (the organization) sponsors various university research programs with the expectation that through innovation, ingenuity and commitment the best clinical results for patients can be achieved. Based on these research efforts and collaborations with external medical advisors, the organization has ongoing programs for improving the processing of allograft tissue. Typical results are greater amounts of usable tissue, satisfying the desire of donors and their families to help others. The organization also provides allograft tissue for studies to further promote improved patient outcomes through the use of allografts. In addition, joint restoration foundation supports 501(c)(3) organizations by making grants to promote donation awareness and education.

$262K in expenses

Education: joint restoration foundation (the organization) annually conducts/supports 6-8 educational symposiums, surgical training courses, and hands-on clinical sessions with surgeons and allied healthcare providers to affect positive surgical outcomes for patients using allograft tissue. Another critical component of the organization's education and service is attendance and sponsorship of 6-8 nationally recognized surgical conferences. Surgeons and related staff are able to learn about the technology provided by the organization and become more familiar with technical advances using allograft tissue.